MwanzoGOVXW • NASDAQ
add
GeoVax
Bei iliyotangulia
$ 0.14
Bei za siku
$ 0.12 - $ 0.15
Bei za mwaka
$ 0.020 - $ 34.93
Thamani ya kampuni katika soko
27.84M USD
Wastani wa hisa zilizouzwa
elfu 16.01
Habari za soko
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
| (USD) | Sep 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato | 2.79M | — |
Matumizi ya uendeshaji wa biashara | 1.24M | -24.86% |
Mapato halisi | -5.82M | 30.84% |
Kiwango cha faida halisi | -208.48 | — |
Mapato kwa kila hisa | — | — |
EBITDA | -5.82M | 32.14% |
Asilimia ya kodi ya mapato | — | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
| (USD) | Sep 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | 8.59M | -32.27% |
Jumla ya mali | 11.11M | -31.41% |
Jumla ya dhima | 2.61M | -63.17% |
Jumla ya hisa | 8.50M | — |
hisa zilizosalia | 9.44M | — |
Uwiano wa bei na thamani | 0.14 | — |
Faida inayotokana na mali | -192.49% | — |
Faida inayotokana mtaji | -461.94% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
| (USD) | Sep 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato halisi | -5.82M | 30.84% |
Pesa kutokana na shughuli | -9.30M | -82.45% |
Pesa kutokana na uwekezaji | elfu -20.65 | -233.54% |
Pesa kutokana na ufadhili | 16.35M | — |
Mabadiliko halisi ya pesa taslimu | 7.03M | 237.81% |
Mtiririko huru wa pesa | -7.18M | -234.67% |
Kuhusu
GeoVax is a clinical-stage biotechnology company which develops vaccines. GeoVax's development platform uses Modified Vaccinia Ankara vector technology, with improvements to antigen design and manufacturing capabilities. GeoVax uses recombinant DNA or recombinant viruses to produce virus-like particles in the person being vaccinated. Wikipedia
Afisa Mkuu Mtendaji (CEO)
Ilianzishwa
1988
Makao Makuu
Tovuti
Wafanyakazi
17
